Differences between users’ and addiction medicine experts’ harm and benefit assessments of licit and illicit psychoactive drugs: Input for psychoeducation and legalization/restriction debates

Differences between users’ and addiction medicine experts’ harm and benefit assessments of licit and illicit psychoactive drugs: Input for psychoeducation and legalization/restriction debates

BackgroundThere is a lack of benefit/harm assessments of illicit and licit psychoactive substances performed by substance-dependent users in comparison to addiction medicine experts.MethodsWe extended the analyses of substance harm/benefit assessments of German addiction medicine experts (N = 101),...

Full description

Bibliographic Details
Main Authors: Udo Bonnet, Michael Specka, Ann-Kristin Kanti, Norbert Scherbaum
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Psychiatry
Subjects:
traditional illicit drugs
cannabis
new psychoactive drugs
ketamine
assessment bias
prescription drugs
Online Access:https://www.frontiersin.org/articles/10.3389/fpsyt.2022.1041762/full

Internet

https://www.frontiersin.org/articles/10.3389/fpsyt.2022.1041762/full

Similar Items